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Abstract
Congenital Zika Syndrome (CZS) is characterized by many impairments especially in the central nervous system, potentially 
compromising neurodevelopment and causing significant morbidity in affected children. The aim was to assess gross motor 
function in children with CZS. This was a cross-sectional investigation nested within a prospective cohort study of children 
with CZS based in a Brazilian referral hospital in Rio de Janeiro. Between March/2017 and February/2018, we performed 
gross motor function assessments using the Gross Motor Function Classification (GMFCS) and the Gross Motor Function 
Measure (GMFM), estimating the mean and standard deviation of GMFM scores among GMFCS groups. The study sample 
included 72 children, with a median age of 13 months (7–25). Of these, 63 (87.5%) had severe motor impairment, 3 (4%) had 
moderate impairment, and 6 (8%) had mild impairment. The mean GMFM score for each group was respectively 11.6, 26.1, 
and 81.6, with statistically significant differences (p-value < 0.001). Severely affected children only achieved head control 
in the sitting posture when supported. Children with milder forms were able to develop walking skills.
Conclusion: Most children with CZS have major motor disabilities and a poor prognosis. Better understanding of limita- 
tions and functionality in children with CZS can serve as a prognostic guide in their management.
What is Known:
• Severe motor impairment was present in 63 (87.5%) children with CZS.
• The degree of neurological impairment was inversely associated with motor performance.
What is New:
• Microcephaly was more frequent among children with severe gross motor function impairment.
• Children with CZS have major motor disabilities and a poor prognosis.
Keywords Zika · Zika virus infection · Neurodevelopmental disorders
Fetal infection by Zika virus (ZIKV) may disrupt brain 
embryogenesis and result in microcephaly and other neu-
rological abnormalities, including subcortical parenchymal 
calcifications, ventriculomegaly, and cortical migration 
abnormalities [1, 2]. Congenital Zika Syndrome (CZS) is 
characterized by the presence of these central nervous sys-
tem (CNS) abnormalities as well as osteoarticular deformi-
ties and hearing and/or visual impairments, which may com-
promise neurodevelopment and cause significant morbidity 
in affected children [1–5]. These sensory and motor altera-
tions are similar to those present in children with cerebral 
palsy (CP) who have musculoskeletal and neural restrictions 
that impede the acquisition of functional abilities [6–8]. 
Motor changes in CZS are often associated with cognitive, 
communication, and behavioral disorders that prevent chil-
dren from reaching developmental milestones [6, 7]. The 
Gross Motor Function Measure (GMFM) was designed and 
validated to assess changes in gross motor function over time 
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in children with CP [9, 10] and it can be an efficient tool 
for assessing neurodevelopment of children with CZS. The 
Gross Motor Function Classification System (GMFCS) is 
used to define a child’s ability and functional limitations, 
serving as a guide to inform motor prognosis [11]. The pur-
pose of this study was to assess gross motor function in chil-
dren with CZS, a recently described clinical condition with 
scarce data available on the neurodevelopmental trajectories 
of affected populations.
Methods
The study was conducted at the National Institute of Women, 
Children and Adolescents Health Fernandes Figueira, 
Oswaldo Cruz Foundation (IFF-Fiocruz), a major referral 
center for congenital infections in Rio de Janeiro, Brazil. 
Infants with presumed CZS were enrolled in a longitudinal 
cohort during the ZIKV outbreak in Brazil in 2015–2016. 
The study population was comprised of children with CZS 
who were evaluated in this study once between the ages of 
7 and 25 months from March 2017 to February 2018. This 
cross-sectional study nested within a cohort was approved 
by the IFF-Fiocruz institutional review board (Plataforma 
Brasil, CAAE: 52,675,616.0.0000.5269). Parents or guard-
ians provided written informed consent for their children’s 
participation.
The study sample included children, older than 6 months, 
born during or immediately after the ZIKV outbreak in Rio 
de Janeiro, Brazil. Children with presumed/probable CZS 
were defined as having characteristic clinical features, neu-
rological manifestations, neuroimaging abnormalities, and/
or ocular alterations typical of congenital ZIKV infection, 
assessed by neurofunctional physical therapy. Children with 
confirmed CZS had all the features of children with pre-
sumed/probable CZS plus laboratory confirmation of mater-
nal or fetal infection. The characteristic clinical phenotype 
of CZS included: microcephaly, overlapping cranial sutures, 
partially collapsed skull, prominent occipital bone, redun-
dant scalp skin, and/or severe neurological impairment, with 
or without accompanying arthrogryposis. Neurological man-
ifestations included: irritability, hypertonia and spasticity, 
hypotonia, hyperreflexia, and/or seizures. The alterations 
considered in the neuroimaging exams included: intracranial 
calcifications, ventriculomegaly and extra-axial fluid, abnor-
mal gyral pattern (e.g., polymicrogyria), decreased cerebral 
parenchymal volume, cortical atrophy and malformations, 
cerebellar or cerebellar vermis hypoplasia, delayed myeli-
nation, and hypoplasia of the corpus callosum. The typical 
ocular alterations included: hypoplasia or pallor of the optic 
nerve, increased cup-to-disc ratio, chorioretinal atrophy or 
scar, pigment mottling, hemorrhagic retinopathy and abnor-
mal retinal vasculature.
Children with arthrogryposis or other osteoarticular con-
genital malformations were excluded from the analysis to 
reduce confounding factors in motor assessment. Other con-
genital infections within the TORCH group, such as toxo-
plasmosis, rubella, cytomegalovirus infection, and herpes 
simplex virus infection were excluded by negative serology. 
Microcephaly was defined as head-circumference at birth 
below -2 standard deviations for gestational age and gender 
(z-score -2). Similarly, severe microcephaly was defined as 
a head-circumference at birth below z-score -3. We used the 
INTERGROWTH-21st Project online software to calculate 
Z-scores for birth measurements based on gestational age 
and sex (http:// inter growt h21. ndog. ox. ac. uk) [12–14].
Each child was evaluated once by a GMFM-trained 
physical therapist (ICC > 0.98 for trained) and was classi-
fied according to the GMFCS-88. We assessed 88 items in 
the following dimensions: (A) Lying and rolling; (B) Sitting; 
(C) Crawling and kneeling; (D) Standing; and (E) Walk-
ing, running, and jumping. Children were also classified in 
5 progressive levels of independence and functionality by 
GMFCS total score. Level I indicates the ability to walk 
without any restrictions. Level II indicates some limitations 
in gait. At level III, children need some assistance to walk. 
At level IV, children need assistive technology equipment 
to move. Level V is reserved for children with severe move-
ment limitations even with the aid of modern technology 
and total dependence for performance of routine tasks. For 
analysis purposes, we classified children at levels I and II 
as having mild impairment, at level III as having moderate 
impairment, and at levels IV and V as severe impairment; 
and the GMFM were described quantitatively according 
to the standardization of the scale with percentage of each 
dimension and total percentage. Data were analyzed as the 
mean and standard deviation of these percentages according 
to the groups of functional impairment [15–17]. Additional 
information on age, sex, head circumference at birth and 
prenatal ZIKV infection confirmation (i.e., maternal infec-
tion during pregnancy or congenital infection confirmed at 
birth) was extracted from medical records.
Data was stored in an EPIINFO 7 database. The data 
analysis was descriptive with measures of central tendency 
and position and measures of dispersion. GMFM results 
were analyzed by the Gross Motor Ability Estimator soft-
ware (GMAE). Analysis of gross motor function occurred 
through the mean and standard deviation by disease severity 
groups. Kruskal–Wallis tests were used to test for differences 
between groups for continuous variables and chi-square tests 
were used for categorical variables. The Spearman correla-
tion index was used to verify the association between the 
GMFCS functional classification categories and the GMFM-
88 total scores (percentage). Statistical Package for Social 
Sciences (SPSS) version 20.0 was used, and the significance 
level of α = 0.05 was considered.
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Results
Seventy-two children with CZS were evaluated, of whom 
39 (54%) were male, with ages ranging from 7 to 24 months 
(median age 13 months). Prenatal ZIKV infection was con-
firmed via real-time reverse-transcriptase–polymerase-chain 
reaction (RT-PCR) assays in 31 (43%) cases for either the 
mother, neonate, or both.
Most children, 63 (88%) cases, had severe gross motor 
impairment, 3 (4%) had moderate impairment, and 6 
(8%) had mild impairment. There was no significant dif-
ference between groups regarding age and sex (Table 1). 
Microcephaly was more frequent in the severe gross motor 
function impairment group, occurring in 51 (83%) cases, 
with a statistically significant difference between groups 
(p-value = 0.001, Chi-squared test). In fact, 35 (56%) chil-
dren from this group presented with severe microcephaly. 
Nevertheless, microcephaly was also observed in 2 children 
with mild gross motor function impairment. Most children 
underwent physical therapy and started treatment by a mean 
age of 4.7 months (range: 1 to 16 months; SD: 3.0).
The mean GMFM score was 81.6 (ranging from 75 to 
90) in the mild impairment group, 26.1 (19 to 33) in the 
moderate impairment group and 11.6 (4 to 22) in the severe 
impairment group. There was a statistically significant dif-
ference between groups (p-value < 0.001, ANOVA test). 
The mean total GMFM score was 17.6 and the median 
(range) score was 11.5 (3.7–90.3). Only 9 (12.5%) chil-
dren did not undergo physical therapy. Spearman correla-
tion index revealed a negative and statistically significant 
association between GMFCS groups and GMFM score 
(−0.6; p-value < 0.001).
Regarding GMFM results, the severely impaired group, 
which corresponded to 88% of the children, was func-
tionally limited and therefore only scored in the first two 
dimensions for (A) lying and rolling (mean score = 38.8), 
and (B) sitting (mean score = 16.8). In comparison, chil-
dren in the moderately impaired group had higher scores 
in the second dimension (sitting), with many being able 
to remain seated without upper limb support, and some 
even had some abilities on dimension C (crawling and 
kneeling), with a mean score of 4.0 in this dimension. 
On the other hand, children in the mildly impaired group 
had fewer limitations in their gross motor skills, and a 
subset were able to reach some abilities of dimension E 
(walking, running and jumping), with a mean score of 36.4 
(Table 2).
Discussion
The study results demonstrate an association between the 
degree of neurological impairment, as indicated by GMFCS 
level, and gross motor performance in children with CZS, 
as previously described in the CP literature [8, 12, 18–20]. 
As described in CP studies [15, 21], children with severe 
impairment (GMFCS levels IV and V) also had severe 
impairment of gross motor function, with a low mean 
GMFM score. Severely impaired children in our study were 
unable to achieve more advanced postures (such as sitting, 
Table 1  Description of 
study population according 
to GMFCS classification as 
mild, moderate, and severe 
impairment groups




Number of participants n = 6 n = 3 n = 63 N = 72
Mean (SD) age in months 14.5 (1.4) 11.7 (0.6) 14.1 (4.7) 13.9 (4.4)
Sex Female 3 (50.0%) 1 (33.3%) 29 (46.0%) 33 (45.8%)
Male 3 (50.0%) 2 (66.7%) 34 (54.0%) 39 (54.2%)
Microcephaly Yes 2 (33.3%) 0 51 (81.0%) 53 (73.6%)
No 4 (66.7%) 3 (100%) 12 (19.0%) 19 (26.4%)
Microcephaly severity Moderate 1 (50.0%) 0 16 (31.4%) 17 (32.1%)
Severe 1 (50.0%) 0 35 (68.6%) 36 (67.9%)
ZIKV detection
(RT-PCR)
Yes 4 (66.7%) 2 (66.7%) 25 (39.7%) 31 (43%)
No 2 (33.3%) 1 (33.3%) 38 (60.3%) 41 (57%)
Physical therapy Yes 4 (66.7%) 3 (100%) 56 (88.9%) 65 (87.5%)
No 2 (33.3%) 0 7 (11.1%) 9 (12.5%)
GMFCS levels I = 0
II = 6
II = 3 IV = 42
V = 21
–
Mean (SD) GMFM 81.6 (5.9) 26.1 (7.0) 11.6 (3.6) 17.6 (20.2)
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crawling and walking), with some only reaching head control 
in the sitting posture when supported by the therapist. Also 
of note, despite neuromotor impairments, some children 
with milder forms of CZS, especially regarding muscle tone, 
were able to reach gait and other more elaborate functions 
in orthostatic posture, such as leaping and kicking a ball.
Using the GMFCS tool, 88% of children were classified in 
levels IV or V, indicating a more severe motor impairment and 
the need for assistance for performance of daily tasks. Such 
impairment was similar to that described in other case series 
of CZS [22–24]. In a study with 77 children with CZS, [22] 
observed that 97.4% (n = 75) had severe functional impairment 
(GMFCS IV and V) and only 2.6% (n = 2) had mild functional 
impairment (GMFCS I); however, the inclusion of children 
with arthrogryposis may have increased the frequency of seri-
ous abnormalities. Carvalho et al. [23] evaluated 69 children 
with CZS, of whom 4 had arthrogryposis, and observed that 
only 7% (n = 5) were classified as GMFCS I to III and 93% 
(n = 64) were classified as GMFCS IV or V. A recent study [24] 
with 110 children born with CZS had similar findings, where 
90.2% of children had GMFCS V, 4.9% had GMFCS IV, 2% 
GMFCS III and 2.9% GMFCS I. The present study did not 
include children with arthrogryposis in order to avoid interfer-
ence in GMFM scoring. The literature has already described 
the association between congenital orthopedic abnormalities 
and worse neurological outcome [25–27].
Children with CZS and muscle tone, sensory (visual and/
or auditory) or orthopedic (hip dislocation and/or arthro-
gryposis) abnormalities have greater limitations in perfor-
mance of daily tasks and are restricted in their ability to 
participate in age-appropriate activities. This can be further 
compounded by limited resources restricting access to medi-
cation, physical therapy or assistive technology [8]. Ferreira 
et al. [7] described a variety of structural and functional 
deficiencies in children with CZS, such as dysphagia, cogni-
tive and language disorders, altered muscle tone, decreased 
control of voluntary movements and decreased joint mobil-
ity. These deficiencies deeply impacted performance of daily 
activities, as fine motor development was not age-appropriate 
in more than 90% of the children, who were also unable to 
walk. Another study by [19] analyzed 24 children with CZS 
and identified hyperreflexia in 100% of the sample, increased 
muscle tone in 95% and clonus in 77%. No child was able to 
stand or walk even with support, which denotes a significant 
motor delay. The present study results have demonstrated 
similar findings.
In the current study, the mean GMFM score was 11.5 
(range: 3.7–90.3). Furthermore, there was an inverse asso- 
ciation between GMFCS groups and GMFM scores, indi- 
cating the higher the level of GMFCS (greater functional 
impairment), the lower the GMFM score. Melo et al. [18] 
analyzed a group of children with CZS between 5 and 
29 months of age and showed a mean GMFM score of 6.5 
(range: 2–82.9), which is lower than that observed in this 
study.
GMFM and GMFCS are promising tools for improving the 
understanding of limitations and prognosis of children with 
CZS. They serve as a guide for tailoring care and informing 
health care and educational policies and priorities [10, 12]. The 
poor motor prognosis in our study participants raises concerns 
about prospects for the group’s full participation in the daily 
activities of society without substantial long-term support.
We used GMFM-88 instead of the reduced version of the 
scale, GMFM-66, since the full version is more sensitive for 
detection of alterations in dimensions A and B [28]. Younger 
and/or severely affected children are mostly able to reach 
developmental milestones in the first two dimensions; the 
research study sample was evaluated at a young age (mean of 
13.9 months) and was mostly considered severely impaired. 
Therefore, GMFM-88 appears to be an appropriate tool to 
evaluate gross motor function in children with CZS.
As seen in Table 2, the group with severe impairment 
according to GMGCS levels, scored only in the first two 
dimensions (A) lying and rolling and (B) sitting, which dem-
onstrates that they had a worse prognosis, with difficulties in 
performing simple tasks independently. Children in the group 
with moderate impairment managed to remain seated with-
out support from the upper limb and even had some skills in 
dimension C (crawling and kneeling). These children have 
the ability to perform postural shifts with greater independ-
ence, but they may present postural compensations, like to 
sit with lumbar hyperkiohosis [23, 29]. Children in the group 
with mild impairment managed to score in all dimensions, 
and some of them were already walking. These results are 
expected, especially for those in the severe group, and have 
been observed in other studies of children with CZS [6, 8, 22].
The presence of microcephaly at birth is another impor-
tant factor for the impact of ZIKV congenital infection on 
neurological development [3, 6, 19, 30, 31]. Gordon-Lipkin 
Table 2  Mean (SD) GMFM scores in each dimension according to 
gross motor function impairment groups









100 (0) 84.3 (16.7) 38.3 (14.9)
Dimension B
(sitting)
98.6 (2.2) 42.2 (12.5) 16.8 (6.2)
Dimension C
(crawling and kneeling)
90.0 (11.3) 4.0 (6.9) 0 (0)
Dimension D
(standing)
83.3 (9.3) 0 (0) 0 (0)
Dimension E
(walking, running, and jump-
ing)
36.4 (15.7) 0 (0) 0 (0)
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et al. [32] have demonstrated that congenital microcephaly 
is associated with gross motor development abnormalities 
in 65% of cases [31]. Microcephaly in CZS is caused by a 
disruptive process [7, 13]. Severe microcephaly is caused by 
brain growth arrest, mainly affecting the frontal, temporal and 
parietal lobes [7, 32]. There is a close relationship between 
neuromotor development delay and the degree of microceph-
aly, as the impaired head growth is indicative of the extent of 
brain damage [2, 8, 33, 34]. The study results corroborate these 
findings, since severe microcephaly was more frequent in the 
group of children classified as severely impaired by GMFCS.
It is important that longitudinal cohort studies evaluating 
sensorineural development use standardized scales. A recent 
study in the northeastern region of Brazil was the first to 
analyze motor development of children with CZS over time; 
this study reported advances in motor development in the first 
18 months of age [22]. However, at 24 months of age, most 
children had reached 90% of their final motor abilities [22].
Although the present study was cross-sectional, prospec-
tive studies of children with CZS are essential for the under-
standing of the natural history of congenital ZIKV infection, 
motor development of affected children, and their functional 
impairments. Although exclusion of children with arthro-
gryposis can be considered a study limitation in the present 
study, their inclusion would have negatively impacted gross 
motor development results in CZS. Another limitation the 
asymmetrical distribution of participants between groups, 
which may have affected our statistical analysis.
Conclusion
Low mean GMFM scores in this population, where most 
children were classified as GMFCS IV and V, demonstrate 
the severe functional impairment and poor prognosis of chil-
dren born with CZS. Our results highlight the pressing need 
for attention to the neurodevelopment of this population with 
the implementation of early stimulation programs, public 
health policies and inclusive education, in order to reduce 
the burden of disease and allow for better motor and sensory 
development in affected children.
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